✦ LIBER ✦

Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study

✍ Scribed by Kimball, A.B.; Papp, K.A.; Wasfi, Y.; Chan, D.; Bissonnette, R.; Sofen, H.; Yeilding, N.; Li, S.; Szapary, P.; Gordon, K.B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy of ustekinumab in pat

✍ A.B. Kimball; K.B. Gordon; S. Fakharzadeh; N. Yeilding; P.O. Szapary; B. Schenke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 385 KB

Long-term safety of ustekinumab in patie

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Long-term safety of ustekinumab in patie

✍ Papp, K.A.; Griffiths, C.E.M.; Gordon, K.; Lebwohl, M.; Szapary, P.O.; Wasfi, Y. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Long-term efficacy of up to 15 months’ e

✍ Darryl P. Toth; Kim Papp; David Gratton 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB

Sustained improvement in skin disease–sp

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Ustekinumab improves health-related qual

✍ M. Lebwohl; K. Papp; C. Han; B. Schenkel; N. Yeilding; Y. Wang; G.G. Krueger 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB